Global Pharmaceutical R&D Outsourcing Services (CRO) Market Growth (Status and Outlook) 2026-2032

July 2026 | 109 pages | ID: G3DBE1F62619EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global Pharmaceutical R&D Outsourcing Services (CRO) market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.

United States market for Pharmaceutical R&D Outsourcing Services (CRO) is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

China market for Pharmaceutical R&D Outsourcing Services (CRO) is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Europe market for Pharmaceutical R&D Outsourcing Services (CRO) is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Global key Pharmaceutical R&D Outsourcing Services (CRO) players cover IQVIA HOLDINGS, ICON (incl. PRA Health), PPD(Pharmaceutical Product Development), Laboratory Corporation, Syneos Health, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.

LPI (LP Information)' newest research report, the ?Pharmaceutical R&D Outsourcing Services (CRO) Industry Forecast? looks at past sales and reviews total world Pharmaceutical R&D Outsourcing Services (CRO) sales in 2025, providing a comprehensive analysis by region and market sector of projected Pharmaceutical R&D Outsourcing Services (CRO) sales for 2026 through 2032. With Pharmaceutical R&D Outsourcing Services (CRO) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pharmaceutical R&D Outsourcing Services (CRO) industry.

This Insight Report provides a comprehensive analysis of the global Pharmaceutical R&D Outsourcing Services (CRO) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Pharmaceutical R&D Outsourcing Services (CRO) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Pharmaceutical R&D Outsourcing Services (CRO) market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pharmaceutical R&D Outsourcing Services (CRO) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pharmaceutical R&D Outsourcing Services (CRO).

This report presents a comprehensive overview, market shares, and growth opportunities of Pharmaceutical R&D Outsourcing Services (CRO) market by product type, application, key players and key regions and countries.

Segmentation by Type:
  • Chemical Drug Research And Development
  • Biological Drug Research And Development
  • Traditional Chinese Medicine Research And Development
Segmentation by Application:
  • Drug Discovery And Early Research
  • Preclinical Research
  • Clinical Trials
  • Post-Marketing Follow-Up
  • Other
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
  • IQVIA HOLDINGS
  • ICON (incl. PRA Health)
  • PPD(Pharmaceutical Product Development)
  • Laboratory Corporation
  • Syneos Health
  • Parexel
  • Covance
  • Charles River Laboratories
  • Wuxi AppTec
  • Pharmaron Inc.
  • Hangzhou Tigermed Consulting
  • IQVIA
  • Joinn Laboratories (China)
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Pharmaceutical R&D Outsourcing Services (CRO) Market Size (2021-2032)
  2.1.2 Pharmaceutical R&D Outsourcing Services (CRO) Market Size CAGR by Region (2021 VS 2025 VS 2032)
  2.1.3 World Current & Future Analysis for Pharmaceutical R&D Outsourcing Services (CRO) by Country/Region (2021, 2025 & 2032)
2.2 Pharmaceutical R&D Outsourcing Services (CRO) Segment by Type
  2.2.1 Chemical Drug Research And Development
  2.2.2 Biological Drug Research And Development
  2.2.3 Traditional Chinese Medicine Research And Development
  2.2.4 Pharmaceutical R&D Outsourcing Services (CRO) Market Size by Type
    2.2.4.1 Pharmaceutical R&D Outsourcing Services (CRO) Market Size CAGR by Type (2021 VS 2025 VS 2032)
    2.2.4.2 Global Pharmaceutical R&D Outsourcing Services (CRO) Market Size Market Share by Type (2021-2026)
2.3 Pharmaceutical R&D Outsourcing Services (CRO) Segment by Application
  2.3.1 Drug Discovery And Early Research
  2.3.2 Preclinical Research
  2.3.3 Clinical Trials
  2.3.4 Post-Marketing Follow-Up
  2.3.5 Other
  2.3.6 Pharmaceutical R&D Outsourcing Services (CRO) Market Size by Application
    2.3.6.1 Pharmaceutical R&D Outsourcing Services (CRO) Market Size CAGR by Application (2021 VS 2025 VS 2032)
    2.3.6.2 Global Pharmaceutical R&D Outsourcing Services (CRO) Market Size Market Share by Application (2021-2026)

3 PHARMACEUTICAL R&D OUTSOURCING SERVICES (CRO) MARKET SIZE BY PLAYER

3.1 Pharmaceutical R&D Outsourcing Services (CRO) Market Size Market Share by Player
  3.1.1 Global Pharmaceutical R&D Outsourcing Services (CRO) Revenue by Player (2021-2026)
  3.1.2 Global Pharmaceutical R&D Outsourcing Services (CRO) Revenue Market Share by Player (2021-2026)
3.2 Global Pharmaceutical R&D Outsourcing Services (CRO) Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 PHARMACEUTICAL R&D OUTSOURCING SERVICES (CRO) BY REGION

4.1 Pharmaceutical R&D Outsourcing Services (CRO) Market Size by Region (2021-2026)
4.2 Global Pharmaceutical R&D Outsourcing Services (CRO) Annual Revenue by Country/Region (2021-2026)
4.3 Americas Pharmaceutical R&D Outsourcing Services (CRO) Market Size Growth (2021-2026)
4.4 APAC Pharmaceutical R&D Outsourcing Services (CRO) Market Size Growth (2021-2026)
4.5 Europe Pharmaceutical R&D Outsourcing Services (CRO) Market Size Growth (2021-2026)
4.6 Middle East & Africa Pharmaceutical R&D Outsourcing Services (CRO) Market Size Growth (2021-2026)

5 AMERICAS

5.1 Americas Pharmaceutical R&D Outsourcing Services (CRO) Market Size by Country (2021-2026)
5.2 Americas Pharmaceutical R&D Outsourcing Services (CRO) Market Size by Type (2021-2026)
5.3 Americas Pharmaceutical R&D Outsourcing Services (CRO) Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Pharmaceutical R&D Outsourcing Services (CRO) Market Size by Region (2021-2026)
6.2 APAC Pharmaceutical R&D Outsourcing Services (CRO) Market Size by Type (2021-2026)
6.3 APAC Pharmaceutical R&D Outsourcing Services (CRO) Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Pharmaceutical R&D Outsourcing Services (CRO) Market Size by Country (2021-2026)
7.2 Europe Pharmaceutical R&D Outsourcing Services (CRO) Market Size by Type (2021-2026)
7.3 Europe Pharmaceutical R&D Outsourcing Services (CRO) Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Pharmaceutical R&D Outsourcing Services (CRO) by Region (2021-2026)
8.2 Middle East & Africa Pharmaceutical R&D Outsourcing Services (CRO) Market Size by Type (2021-2026)
8.3 Middle East & Africa Pharmaceutical R&D Outsourcing Services (CRO) Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL PHARMACEUTICAL R&D OUTSOURCING SERVICES (CRO) MARKET FORECAST

10.1 Global Pharmaceutical R&D Outsourcing Services (CRO) Forecast by Region (2027-2032)
  10.1.1 Global Pharmaceutical R&D Outsourcing Services (CRO) Forecast by Region (2027-2032)
  10.1.2 Americas Pharmaceutical R&D Outsourcing Services (CRO) Forecast
  10.1.3 APAC Pharmaceutical R&D Outsourcing Services (CRO) Forecast
  10.1.4 Europe Pharmaceutical R&D Outsourcing Services (CRO) Forecast
  10.1.5 Middle East & Africa Pharmaceutical R&D Outsourcing Services (CRO) Forecast
10.2 Americas Pharmaceutical R&D Outsourcing Services (CRO) Forecast by Country (2027-2032)
  10.2.1 United States Market Pharmaceutical R&D Outsourcing Services (CRO) Forecast
  10.2.2 Canada Market Pharmaceutical R&D Outsourcing Services (CRO) Forecast
  10.2.3 Mexico Market Pharmaceutical R&D Outsourcing Services (CRO) Forecast
  10.2.4 Brazil Market Pharmaceutical R&D Outsourcing Services (CRO) Forecast
10.3 APAC Pharmaceutical R&D Outsourcing Services (CRO) Forecast by Region (2027-2032)
  10.3.1 China Pharmaceutical R&D Outsourcing Services (CRO) Market Forecast
  10.3.2 Japan Market Pharmaceutical R&D Outsourcing Services (CRO) Forecast
  10.3.3 Korea Market Pharmaceutical R&D Outsourcing Services (CRO) Forecast
  10.3.4 Southeast Asia Market Pharmaceutical R&D Outsourcing Services (CRO) Forecast
  10.3.5 India Market Pharmaceutical R&D Outsourcing Services (CRO) Forecast
  10.3.6 Australia Market Pharmaceutical R&D Outsourcing Services (CRO) Forecast
10.4 Europe Pharmaceutical R&D Outsourcing Services (CRO) Forecast by Country (2027-2032)
  10.4.1 Germany Market Pharmaceutical R&D Outsourcing Services (CRO) Forecast
  10.4.2 France Market Pharmaceutical R&D Outsourcing Services (CRO) Forecast
  10.4.3 UK Market Pharmaceutical R&D Outsourcing Services (CRO) Forecast
  10.4.4 Italy Market Pharmaceutical R&D Outsourcing Services (CRO) Forecast
  10.4.5 Russia Market Pharmaceutical R&D Outsourcing Services (CRO) Forecast
10.5 Middle East & Africa Pharmaceutical R&D Outsourcing Services (CRO) Forecast by Region (2027-2032)
  10.5.1 Egypt Market Pharmaceutical R&D Outsourcing Services (CRO) Forecast
  10.5.2 South Africa Market Pharmaceutical R&D Outsourcing Services (CRO) Forecast
  10.5.3 Israel Market Pharmaceutical R&D Outsourcing Services (CRO) Forecast
  10.5.4 Turkey Market Pharmaceutical R&D Outsourcing Services (CRO) Forecast
10.6 Global Pharmaceutical R&D Outsourcing Services (CRO) Forecast by Type (2027-2032)
10.7 Global Pharmaceutical R&D Outsourcing Services (CRO) Forecast by Application (2027-2032)
  10.7.1 GCC Countries Market Pharmaceutical R&D Outsourcing Services (CRO) Forecast

11 KEY PLAYERS ANALYSIS

11.1 IQVIA HOLDINGS
  11.1.1 IQVIA HOLDINGS Company Information
  11.1.2 IQVIA HOLDINGS Pharmaceutical R&D Outsourcing Services (CRO) Product Offered
  11.1.3 IQVIA HOLDINGS Pharmaceutical R&D Outsourcing Services (CRO) Revenue, Gross Margin and Market Share (2021-2026)
  11.1.4 IQVIA HOLDINGS Main Business Overview
  11.1.5 IQVIA HOLDINGS Latest Developments
11.2 ICON (incl. PRA Health)
  11.2.1 ICON (incl. PRA Health) Company Information
  11.2.2 ICON (incl. PRA Health) Pharmaceutical R&D Outsourcing Services (CRO) Product Offered
  11.2.3 ICON (incl. PRA Health) Pharmaceutical R&D Outsourcing Services (CRO) Revenue, Gross Margin and Market Share (2021-2026)
  11.2.4 ICON (incl. PRA Health) Main Business Overview
  11.2.5 ICON (incl. PRA Health) Latest Developments
11.3 PPD(Pharmaceutical Product Development)
  11.3.1 PPD(Pharmaceutical Product Development) Company Information
  11.3.2 PPD(Pharmaceutical Product Development) Pharmaceutical R&D Outsourcing Services (CRO) Product Offered
  11.3.3 PPD(Pharmaceutical Product Development) Pharmaceutical R&D Outsourcing Services (CRO) Revenue, Gross Margin and Market Share (2021-2026)
  11.3.4 PPD(Pharmaceutical Product Development) Main Business Overview
  11.3.5 PPD(Pharmaceutical Product Development) Latest Developments
11.4 Laboratory Corporation
  11.4.1 Laboratory Corporation Company Information
  11.4.2 Laboratory Corporation Pharmaceutical R&D Outsourcing Services (CRO) Product Offered
  11.4.3 Laboratory Corporation Pharmaceutical R&D Outsourcing Services (CRO) Revenue, Gross Margin and Market Share (2021-2026)
  11.4.4 Laboratory Corporation Main Business Overview
  11.4.5 Laboratory Corporation Latest Developments
11.5 Syneos Health
  11.5.1 Syneos Health Company Information
  11.5.2 Syneos Health Pharmaceutical R&D Outsourcing Services (CRO) Product Offered
  11.5.3 Syneos Health Pharmaceutical R&D Outsourcing Services (CRO) Revenue, Gross Margin and Market Share (2021-2026)
  11.5.4 Syneos Health Main Business Overview
  11.5.5 Syneos Health Latest Developments
11.6 Parexel
  11.6.1 Parexel Company Information
  11.6.2 Parexel Pharmaceutical R&D Outsourcing Services (CRO) Product Offered
  11.6.3 Parexel Pharmaceutical R&D Outsourcing Services (CRO) Revenue, Gross Margin and Market Share (2021-2026)
  11.6.4 Parexel Main Business Overview
  11.6.5 Parexel Latest Developments
11.7 Covance
  11.7.1 Covance Company Information
  11.7.2 Covance Pharmaceutical R&D Outsourcing Services (CRO) Product Offered
  11.7.3 Covance Pharmaceutical R&D Outsourcing Services (CRO) Revenue, Gross Margin and Market Share (2021-2026)
  11.7.4 Covance Main Business Overview
  11.7.5 Covance Latest Developments
11.8 Charles River Laboratories
  11.8.1 Charles River Laboratories Company Information
  11.8.2 Charles River Laboratories Pharmaceutical R&D Outsourcing Services (CRO) Product Offered
  11.8.3 Charles River Laboratories Pharmaceutical R&D Outsourcing Services (CRO) Revenue, Gross Margin and Market Share (2021-2026)
  11.8.4 Charles River Laboratories Main Business Overview
  11.8.5 Charles River Laboratories Latest Developments
11.9 Wuxi AppTec
  11.9.1 Wuxi AppTec Company Information
  11.9.2 Wuxi AppTec Pharmaceutical R&D Outsourcing Services (CRO) Product Offered
  11.9.3 Wuxi AppTec Pharmaceutical R&D Outsourcing Services (CRO) Revenue, Gross Margin and Market Share (2021-2026)
  11.9.4 Wuxi AppTec Main Business Overview
  11.9.5 Wuxi AppTec Latest Developments
11.10 Pharmaron Inc.
  11.10.1 Pharmaron Inc. Company Information
  11.10.2 Pharmaron Inc. Pharmaceutical R&D Outsourcing Services (CRO) Product Offered
  11.10.3 Pharmaron Inc. Pharmaceutical R&D Outsourcing Services (CRO) Revenue, Gross Margin and Market Share (2021-2026)
  11.10.4 Pharmaron Inc. Main Business Overview
  11.10.5 Pharmaron Inc. Latest Developments
11.11 Hangzhou Tigermed Consulting
  11.11.1 Hangzhou Tigermed Consulting Company Information
  11.11.2 Hangzhou Tigermed Consulting Pharmaceutical R&D Outsourcing Services (CRO) Product Offered
  11.11.3 Hangzhou Tigermed Consulting Pharmaceutical R&D Outsourcing Services (CRO) Revenue, Gross Margin and Market Share (2021-2026)
  11.11.4 Hangzhou Tigermed Consulting Main Business Overview
  11.11.5 Hangzhou Tigermed Consulting Latest Developments
11.12 IQVIA
  11.12.1 IQVIA Company Information
  11.12.2 IQVIA Pharmaceutical R&D Outsourcing Services (CRO) Product Offered
  11.12.3 IQVIA Pharmaceutical R&D Outsourcing Services (CRO) Revenue, Gross Margin and Market Share (2021-2026)
  11.12.4 IQVIA Main Business Overview
  11.12.5 IQVIA Latest Developments
11.13 Joinn Laboratories (China)
  11.13.1 Joinn Laboratories (China) Company Information
  11.13.2 Joinn Laboratories (China) Pharmaceutical R&D Outsourcing Services (CRO) Product Offered
  11.13.3 Joinn Laboratories (China) Pharmaceutical R&D Outsourcing Services (CRO) Revenue, Gross Margin and Market Share (2021-2026)
  11.13.4 Joinn Laboratories (China) Main Business Overview
  11.13.5 Joinn Laboratories (China) Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION



LIST OF TABLES

Table 1. Pharmaceutical R&D Outsourcing Services (CRO) Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Pharmaceutical R&D Outsourcing Services (CRO) Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Chemical Drug Research And Development
Table 4. Major Players of Biological Drug Research And Development
Table 5. Major Players of Traditional Chinese Medicine Research And Development
Table 6. Pharmaceutical R&D Outsourcing Services (CRO) Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 7. Global Pharmaceutical R&D Outsourcing Services (CRO) Market Size by Type (2021-2026) & ($ millions)
Table 8. Global Pharmaceutical R&D Outsourcing Services (CRO) Market Size Market Share by Type (2021-2026)
Table 9. Pharmaceutical R&D Outsourcing Services (CRO) Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 10. Global Pharmaceutical R&D Outsourcing Services (CRO) Market Size by Application (2021-2026) & ($ millions)
Table 11. Global Pharmaceutical R&D Outsourcing Services (CRO) Market Size Market Share by Application (2021-2026)
Table 12. Global Pharmaceutical R&D Outsourcing Services (CRO) Revenue by Player (2021-2026) & ($ millions)
Table 13. Global Pharmaceutical R&D Outsourcing Services (CRO) Revenue Market Share by Player (2021-2026)
Table 14. Pharmaceutical R&D Outsourcing Services (CRO) Key Players Head office and Products Offered
Table 15. Pharmaceutical R&D Outsourcing Services (CRO) Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Pharmaceutical R&D Outsourcing Services (CRO) Market Size by Region (2021-2026) & ($ millions)
Table 19. Global Pharmaceutical R&D Outsourcing Services (CRO) Market Size Market Share by Region (2021-2026)
Table 20. Global Pharmaceutical R&D Outsourcing Services (CRO) Revenue by Country/Region (2021-2026) & ($ millions)
Table 21. Global Pharmaceutical R&D Outsourcing Services (CRO) Revenue Market Share by Country/Region (2021-2026)
Table 22. Americas Pharmaceutical R&D Outsourcing Services (CRO) Market Size by Country (2021-2026) & ($ millions)
Table 23. Americas Pharmaceutical R&D Outsourcing Services (CRO) Market Size Market Share by Country (2021-2026)
Table 24. Americas Pharmaceutical R&D Outsourcing Services (CRO) Market Size by Type (2021-2026) & ($ millions)
Table 25. Americas Pharmaceutical R&D Outsourcing Services (CRO) Market Size Market Share by Type (2021-2026)
Table 26. Americas Pharmaceutical R&D Outsourcing Services (CRO) Market Size by Application (2021-2026) & ($ millions)
Table 27. Americas Pharmaceutical R&D Outsourcing Services (CRO) Market Size Market Share by Application (2021-2026)
Table 28. APAC Pharmaceutical R&D Outsourcing Services (CRO) Market Size by Region (2021-2026) & ($ millions)
Table 29. APAC Pharmaceutical R&D Outsourcing Services (CRO) Market Size Market Share by Region (2021-2026)
Table 30. APAC Pharmaceutical R&D Outsourcing Services (CRO) Market Size by Type (2021-2026) & ($ millions)
Table 31. APAC Pharmaceutical R&D Outsourcing Services (CRO) Market Size by Application (2021-2026) & ($ millions)
Table 32. Europe Pharmaceutical R&D Outsourcing Services (CRO) Market Size by Country (2021-2026) & ($ millions)
Table 33. Europe Pharmaceutical R&D Outsourcing Services (CRO) Market Size Market Share by Country (2021-2026)
Table 34. Europe Pharmaceutical R&D Outsourcing Services (CRO) Market Size by Type (2021-2026) & ($ millions)
Table 35. Europe Pharmaceutical R&D Outsourcing Services (CRO) Market Size by Application (2021-2026) & ($ millions)
Table 36. Middle East & Africa Pharmaceutical R&D Outsourcing Services (CRO) Market Size by Region (2021-2026) & ($ millions)
Table 37. Middle East & Africa Pharmaceutical R&D Outsourcing Services (CRO) Market Size by Type (2021-2026) & ($ millions)
Table 38. Middle East & Africa Pharmaceutical R&D Outsourcing Services (CRO) Market Size by Application (2021-2026) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Pharmaceutical R&D Outsourcing Services (CRO)
Table 40. Key Market Challenges & Risks of Pharmaceutical R&D Outsourcing Services (CRO)
Table 41. Key Industry Trends of Pharmaceutical R&D Outsourcing Services (CRO)
Table 42. Global Pharmaceutical R&D Outsourcing Services (CRO) Market Size Forecast by Region (2027-2032) & ($ millions)
Table 43. Global Pharmaceutical R&D Outsourcing Services (CRO) Market Size Market Share Forecast by Region (2027-2032)
Table 44. Global Pharmaceutical R&D Outsourcing Services (CRO) Market Size Forecast by Type (2027-2032) & ($ millions)
Table 45. Global Pharmaceutical R&D Outsourcing Services (CRO) Market Size Forecast by Application (2027-2032) & ($ millions)
Table 46. IQVIA HOLDINGS Details, Company Type, Pharmaceutical R&D Outsourcing Services (CRO) Area Served and Its Competitors
Table 47. IQVIA HOLDINGS Pharmaceutical R&D Outsourcing Services (CRO) Product Offered
Table 48. IQVIA HOLDINGS Pharmaceutical R&D Outsourcing Services (CRO) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 49. IQVIA HOLDINGS Main Business
Table 50. IQVIA HOLDINGS Latest Developments
Table 51. ICON (incl. PRA Health) Details, Company Type, Pharmaceutical R&D Outsourcing Services (CRO) Area Served and Its Competitors
Table 52. ICON (incl. PRA Health) Pharmaceutical R&D Outsourcing Services (CRO) Product Offered
Table 53. ICON (incl. PRA Health) Pharmaceutical R&D Outsourcing Services (CRO) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 54. ICON (incl. PRA Health) Main Business
Table 55. ICON (incl. PRA Health) Latest Developments
Table 56. PPD(Pharmaceutical Product Development) Details, Company Type, Pharmaceutical R&D Outsourcing Services (CRO) Area Served and Its Competitors
Table 57. PPD(Pharmaceutical Product Development) Pharmaceutical R&D Outsourcing Services (CRO) Product Offered
Table 58. PPD(Pharmaceutical Product Development) Pharmaceutical R&D Outsourcing Services (CRO) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 59. PPD(Pharmaceutical Product Development) Main Business
Table 60. PPD(Pharmaceutical Product Development) Latest Developments
Table 61. Laboratory Corporation Details, Company Type, Pharmaceutical R&D Outsourcing Services (CRO) Area Served and Its Competitors
Table 62. Laboratory Corporation Pharmaceutical R&D Outsourcing Services (CRO) Product Offered
Table 63. Laboratory Corporation Pharmaceutical R&D Outsourcing Services (CRO) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 64. Laboratory Corporation Main Business
Table 65. Laboratory Corporation Latest Developments
Table 66. Syneos Health Details, Company Type, Pharmaceutical R&D Outsourcing Services (CRO) Area Served and Its Competitors
Table 67. Syneos Health Pharmaceutical R&D Outsourcing Services (CRO) Product Offered
Table 68. Syneos Health Pharmaceutical R&D Outsourcing Services (CRO) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 69. Syneos Health Main Business
Table 70. Syneos Health Latest Developments
Table 71. Parexel Details, Company Type, Pharmaceutical R&D Outsourcing Services (CRO) Area Served and Its Competitors
Table 72. Parexel Pharmaceutical R&D Outsourcing Services (CRO) Product Offered
Table 73. Parexel Pharmaceutical R&D Outsourcing Services (CRO) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 74. Parexel Main Business
Table 75. Parexel Latest Developments
Table 76. Covance Details, Company Type, Pharmaceutical R&D Outsourcing Services (CRO) Area Served and Its Competitors
Table 77. Covance Pharmaceutical R&D Outsourcing Services (CRO) Product Offered
Table 78. Covance Pharmaceutical R&D Outsourcing Services (CRO) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 79. Covance Main Business
Table 80. Covance Latest Developments
Table 81. Charles River Laboratories Details, Company Type, Pharmaceutical R&D Outsourcing Services (CRO) Area Served and Its Competitors
Table 82. Charles River Laboratories Pharmaceutical R&D Outsourcing Services (CRO) Product Offered
Table 83. Charles River Laboratories Pharmaceutical R&D Outsourcing Services (CRO) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 84. Charles River Laboratories Main Business
Table 85. Charles River Laboratories Latest Developments
Table 86. Wuxi AppTec Details, Company Type, Pharmaceutical R&D Outsourcing Services (CRO) Area Served and Its Competitors
Table 87. Wuxi AppTec Pharmaceutical R&D Outsourcing Services (CRO) Product Offered
Table 88. Wuxi AppTec Pharmaceutical R&D Outsourcing Services (CRO) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 89. Wuxi AppTec Main Business
Table 90. Wuxi AppTec Latest Developments
Table 91. Pharmaron Inc. Details, Company Type, Pharmaceutical R&D Outsourcing Services (CRO) Area Served and Its Competitors
Table 92. Pharmaron Inc. Pharmaceutical R&D Outsourcing Services (CRO) Product Offered
Table 93. Pharmaron Inc. Pharmaceutical R&D Outsourcing Services (CRO) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 94. Pharmaron Inc. Main Business
Table 95. Pharmaron Inc. Latest Developments
Table 96. Hangzhou Tigermed Consulting Details, Company Type, Pharmaceutical R&D Outsourcing Services (CRO) Area Served and Its Competitors
Table 97. Hangzhou Tigermed Consulting Pharmaceutical R&D Outsourcing Services (CRO) Product Offered
Table 98. Hangzhou Tigermed Consulting Pharmaceutical R&D Outsourcing Services (CRO) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 99. Hangzhou Tigermed Consulting Main Business
Table 100. Hangzhou Tigermed Consulting Latest Developments
Table 101. IQVIA Details, Company Type, Pharmaceutical R&D Outsourcing Services (CRO) Area Served and Its Competitors
Table 102. IQVIA Pharmaceutical R&D Outsourcing Services (CRO) Product Offered
Table 103. IQVIA Pharmaceutical R&D Outsourcing Services (CRO) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 104. IQVIA Main Business
Table 105. IQVIA Latest Developments
Table 106. Joinn Laboratories (China) Details, Company Type, Pharmaceutical R&D Outsourcing Services (CRO) Area Served and Its Competitors
Table 107. Joinn Laboratories (China) Pharmaceutical R&D Outsourcing Services (CRO) Product Offered
Table 108. Joinn Laboratories (China) Pharmaceutical R&D Outsourcing Services (CRO) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 109. Joinn Laboratories (China) Main Business
Table 110. Joinn Laboratories (China) Latest Developments

LIST OF FIGURES

Figure 1. Pharmaceutical R&D Outsourcing Services (CRO) Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Pharmaceutical R&D Outsourcing Services (CRO) Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Pharmaceutical R&D Outsourcing Services (CRO) Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Pharmaceutical R&D Outsourcing Services (CRO) Sales Market Share by Country/Region (2025)
Figure 8. Pharmaceutical R&D Outsourcing Services (CRO) Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Pharmaceutical R&D Outsourcing Services (CRO) Market Size Market Share by Type in 2025
Figure 10. Pharmaceutical R&D Outsourcing Services (CRO) in Drug Discovery And Early Research
Figure 11. Global Pharmaceutical R&D Outsourcing Services (CRO) Market: Drug Discovery And Early Research (2021-2026) & ($ millions)
Figure 12. Pharmaceutical R&D Outsourcing Services (CRO) in Preclinical Research
Figure 13. Global Pharmaceutical R&D Outsourcing Services (CRO) Market: Preclinical Research (2021-2026) & ($ millions)
Figure 14. Pharmaceutical R&D Outsourcing Services (CRO) in Clinical Trials
Figure 15. Global Pharmaceutical R&D Outsourcing Services (CRO) Market: Clinical Trials (2021-2026) & ($ millions)
Figure 16. Pharmaceutical R&D Outsourcing Services (CRO) in Post-Marketing Follow-Up
Figure 17. Global Pharmaceutical R&D Outsourcing Services (CRO) Market: Post-Marketing Follow-Up (2021-2026) & ($ millions)
Figure 18. Pharmaceutical R&D Outsourcing Services (CRO) in Other
Figure 19. Global Pharmaceutical R&D Outsourcing Services (CRO) Market: Other (2021-2026) & ($ millions)
Figure 20. Global Pharmaceutical R&D Outsourcing Services (CRO) Market Size Market Share by Application in 2025
Figure 21. Global Pharmaceutical R&D Outsourcing Services (CRO) Revenue Market Share by Player in 2025
Figure 22. Global Pharmaceutical R&D Outsourcing Services (CRO) Market Size Market Share by Region (2021-2026)
Figure 23. Americas Pharmaceutical R&D Outsourcing Services (CRO) Market Size 2021-2026 ($ millions)
Figure 24. APAC Pharmaceutical R&D Outsourcing Services (CRO) Market Size 2021-2026 ($ millions)
Figure 25. Europe Pharmaceutical R&D Outsourcing Services (CRO) Market Size 2021-2026 ($ millions)
Figure 26. Middle East & Africa Pharmaceutical R&D Outsourcing Services (CRO) Market Size 2021-2026 ($ millions)
Figure 27. Americas Pharmaceutical R&D Outsourcing Services (CRO) Value Market Share by Country in 2025
Figure 28. United States Pharmaceutical R&D Outsourcing Services (CRO) Market Size Growth 2021-2026 ($ millions)
Figure 29. Canada Pharmaceutical R&D Outsourcing Services (CRO) Market Size Growth 2021-2026 ($ millions)
Figure 30. Mexico Pharmaceutical R&D Outsourcing Services (CRO) Market Size Growth 2021-2026 ($ millions)
Figure 31. Brazil Pharmaceutical R&D Outsourcing Services (CRO) Market Size Growth 2021-2026 ($ millions)
Figure 32. APAC Pharmaceutical R&D Outsourcing Services (CRO) Market Size Market Share by Region in 2025
Figure 33. APAC Pharmaceutical R&D Outsourcing Services (CRO) Market Size Market Share by Type (2021-2026)
Figure 34. APAC Pharmaceutical R&D Outsourcing Services (CRO) Market Size Market Share by Application (2021-2026)
Figure 35. China Pharmaceutical R&D Outsourcing Services (CRO) Market Size Growth 2021-2026 ($ millions)
Figure 36. Japan Pharmaceutical R&D Outsourcing Services (CRO) Market Size Growth 2021-2026 ($ millions)
Figure 37. South Korea Pharmaceutical R&D Outsourcing Services (CRO) Market Size Growth 2021-2026 ($ millions)
Figure 38. Southeast Asia Pharmaceutical R&D Outsourcing Services (CRO) Market Size Growth 2021-2026 ($ millions)
Figure 39. India Pharmaceutical R&D Outsourcing Services (CRO) Market Size Growth 2021-2026 ($ millions)
Figure 40. Australia Pharmaceutical R&D Outsourcing Services (CRO) Market Size Growth 2021-2026 ($ millions)
Figure 41. Europe Pharmaceutical R&D Outsourcing Services (CRO) Market Size Market Share by Country in 2025
Figure 42. Europe Pharmaceutical R&D Outsourcing Services (CRO) Market Size Market Share by Type (2021-2026)
Figure 43. Europe Pharmaceutical R&D Outsourcing Services (CRO) Market Size Market Share by Application (2021-2026)
Figure 44. Germany Pharmaceutical R&D Outsourcing Services (CRO) Market Size Growth 2021-2026 ($ millions)
Figure 45. France Pharmaceutical R&D Outsourcing Services (CRO) Market Size Growth 2021-2026 ($ millions)
Figure 46. UK Pharmaceutical R&D Outsourcing Services (CRO) Market Size Growth 2021-2026 ($ millions)
Figure 47. Italy Pharmaceutical R&D Outsourcing Services (CRO) Market Size Growth 2021-2026 ($ millions)
Figure 48. Russia Pharmaceutical R&D Outsourcing Services (CRO) Market Size Growth 2021-2026 ($ millions)
Figure 49. Middle East & Africa Pharmaceutical R&D Outsourcing Services (CRO) Market Size Market Share by Region (2021-2026)
Figure 50. Middle East & Africa Pharmaceutical R&D Outsourcing Services (CRO) Market Size Market Share by Type (2021-2026)
Figure 51. Middle East & Africa Pharmaceutical R&D Outsourcing Services (CRO) Market Size Market Share by Application (2021-2026)
Figure 52. Egypt Pharmaceutical R&D Outsourcing Services (CRO) Market Size Growth 2021-2026 ($ millions)
Figure 53. South Africa Pharmaceutical R&D Outsourcing Services (CRO) Market Size Growth 2021-2026 ($ millions)
Figure 54. Israel Pharmaceutical R&D Outsourcing Services (CRO) Market Size Growth 2021-2026 ($ millions)
Figure 55. Turkey Pharmaceutical R&D Outsourcing Services (CRO) Market Size Growth 2021-2026 ($ millions)
Figure 56. GCC Countries Pharmaceutical R&D Outsourcing Services (CRO) Market Size Growth 2021-2026 ($ millions)
Figure 57. Americas Pharmaceutical R&D Outsourcing Services (CRO) Market Size 2027-2032 ($ millions)
Figure 58. APAC Pharmaceutical R&D Outsourcing Services (CRO) Market Size 2027-2032 ($ millions)
Figure 59. Europe Pharmaceutical R&D Outsourcing Services (CRO) Market Size 2027-2032 ($ millions)
Figure 60. Middle East & Africa Pharmaceutical R&D Outsourcing Services (CRO) Market Size 2027-2032 ($ millions)
Figure 61. United States Pharmaceutical R&D Outsourcing Services (CRO) Market Size 2027-2032 ($ millions)
Figure 62. Canada Pharmaceutical R&D Outsourcing Services (CRO) Market Size 2027-2032 ($ millions)
Figure 63. Mexico Pharmaceutical R&D Outsourcing Services (CRO) Market Size 2027-2032 ($ millions)
Figure 64. Brazil Pharmaceutical R&D Outsourcing Services (CRO) Market Size 2027-2032 ($ millions)
Figure 65. China Pharmaceutical R&D Outsourcing Services (CRO) Market Size 2027-2032 ($ millions)
Figure 66. Japan Pharmaceutical R&D Outsourcing Services (CRO) Market Size 2027-2032 ($ millions)
Figure 67. Korea Pharmaceutical R&D Outsourcing Services (CRO) Market Size 2027-2032 ($ millions)
Figure 68. Southeast Asia Pharmaceutical R&D Outsourcing Services (CRO) Market Size 2027-2032 ($ millions)
Figure 69. India Pharmaceutical R&D Outsourcing Services (CRO) Market Size 2027-2032 ($ millions)
Figure 70. Australia Pharmaceutical R&D Outsourcing Services (CRO) Market Size 2027-2032 ($ millions)
Figure 71. Germany Pharmaceutical R&D Outsourcing Services (CRO) Market Size 2027-2032 ($ millions)
Figure 72. France Pharmaceutical R&D Outsourcing Services (CRO) Market Size 2027-2032 ($ millions)
Figure 73. UK Pharmaceutical R&D Outsourcing Services (CRO) Market Size 2027-2032 ($ millions)
Figure 74. Italy Pharmaceutical R&D Outsourcing Services (CRO) Market Size 2027-2032 ($ millions)
Figure 75. Russia Pharmaceutical R&D Outsourcing Services (CRO) Market Size 2027-2032 ($ millions)
Figure 76. Egypt Pharmaceutical R&D Outsourcing Services (CRO) Market Size 2027-2032 ($ millions)
Figure 77. South Africa Pharmaceutical R&D Outsourcing Services (CRO) Market Size 2027-2032 ($ millions)
Figure 78. Israel Pharmaceutical R&D Outsourcing Services (CRO) Market Size 2027-2032 ($ millions)
Figure 79. Turkey Pharmaceutical R&D Outsourcing Services (CRO) Market Size 2027-2032 ($ millions)
Figure 80. Global Pharmaceutical R&D Outsourcing Services (CRO) Market Size Market Share Forecast by Type (2027-2032)
Figure 81. Global Pharmaceutical R&D Outsourcing Services (CRO) Market Size Market Share Forecast by Application (2027-2032)
Figure 82. GCC Countries Pharmaceutical R&D Outsourcing Services (CRO) Market Size 2027-2032 ($ millions)


More Publications